Agenda EURLSSG-Meeting

Friday 12th December 2025, 9:00 - 17:00 h 

 

Welcome and Literature Survey:

RLS publications in the last 12 months
Wolfgang Oertel, President, Germany

 

Epidemiology and genetics in the clinic


Chairperson:
Claudia Trenkwalder, Germany
 

How to assess RLS in large population studies - Expert examination versus classification from questionnaires
Klaus Berger, Germany


 

Genetics

Chairperson:
Klaus Berger, Germanyand Barbara Schormair, Germany

Genetic risk factors for RLS in end-stage renal disease
Noah Risse, München, Germany – Young Investigator


 

RLS and the autonomic system


Chairpersons:
Wolfgang Oertel, Germany and TBD

 

RLS as surrogate for more generalized dysautonomia
Olli Polo, Finland

Significance of central sensitization in the disease process of restless legs syndrome
Yuichi Inoue, Japan

 

 

The role of iron and dopaminergic systems in RLS


Chairperson:
Stefan Clemens, USA and Claudia Trenkwadler, Germany

 

Intravenous iron treatment in patients with restless legs syndrome and Revisiting ferritin thresholds in restless legs syndrome: a sub-analysis of intravenous ferric carboxymaltose treatment
Celia Garcia Malo, Spain


 

RLS and comorbidity in neurological and psychiatric disorders

Chairperson:
Federica Provini, Itlay and Lucia Muntean, Germany

 

Prevalence and predictive factors of RLS in Thai patients with Parkinson’s disease: A preliminary report
Jindapa Srikajon, Thailand

Description and preliminary data of a large population of RLS inpatients from a specialised center of Movement Disorders (Paracelsus Elena Klinik)
Isabel Karger, Germany

Depression and anxiety among people with insomnia with and without RLS
Haykuhi Hovakimyan, Armenia

RLS and PLMS in nocturnal epilepsy vs NREM parasomnia
Elza Balian, Armenia

 

 

Emerging new treatment options, pharmacological and non-pharmacological strategies


Chairperson:
Yves Dauvilliers, France and Samson Khachatryan, Armenia

 

Managing the hyperdopaminergic state of RLS with augmentation: the "bridging" utility of a dopaminergic pathway-stabilizing drug such as aripiprazole
Celia Garcia Malo, Spain

Daridorexant treatment for chronic insomnia in RLS
Claudio Liguori, Italy


Industry partner

Daridorexant in patients with insomnia disorder and comorbid restless leg syndrome: rationale and design of a non-interventional data collection study 
Orestis Briasoulis, Idorsia Pharmaceuticals Ltd, Switzerland

Discussion: clinical trial concepts and design on augmentation

 

 

RLS. Hormons, Circadian Rhythm, Microbiome


Chairpersons:
TBD

 

Sex and gonadotropin hormones in the context of RLS
Sofia Kasradze, Georgia

Analysis of gut microbiota in RLS: searching for metagenomic signature
Angelica Montini, Spain / Italy

RLS after awakening at night: a separate phenotype yet underrecognized – a case-based concept discussion
Samson Khachatryan, Armenia

 

 

RLS Guidelines


Chairpersons:
Ambra Stefani, Austria and TBD

 

An update on treatment guidelines for RLS in Japan
Yukiyoshi Sumi, Austria

Patient-perspective on guidelines (input sent to EAN RLS-guideline group)
Sören Berg, Sweden

Comments on the AASM recommendations for the treatment of RLS
Lucia Muntean, Samson Khachatryan - open round discussion

 

 

RLS Young Researcher Award


Chairperson:
Joachim Paulus, Germany

 

German RLS Society: Ceremony and Lecture
TBD

 

 

 

 

Agenda EURLSSG-Meeting

Saturday 13th December 2025, 9:00 - 14:00 h 

 

Welcome

Wolfgang Oertel, President, Germany

 

Industry Session

Chairpersons:
TBD


TOMAC (Nidra) neurostimulation therapy in patients with refractory RLS; interim results from the THRIVE post-market observational study.
Jonathan Charlesworth, Noctrix Health, Inc., USA

 

 

Restlessness, RLS, ADHD and maternal Sleep: Compromised iron homeostasis in animal models and its manifestation in the clinic

Chairpersons:
Osman Ipsiroglu, Canada and Stefan Clemens, USA


Central Iron Deficiency. Take-home Messages from Animal Studies
Stefan Clemens, USA                                

RLS and PLMS during pregnancy and puerperium: Data from the Life-ON Study
Silvia Riccardi, Switzerland

Mother/Child-Cohort studies in the EU. Sleep-related Outcome Measures
Marianna Karachaliou, The Netherlands

Iron Deficiency Screening beyond RLS: Take-home Messages from the clinic
Osman Ipsiroglu, Canada / Austria

 

 

Common Projects

Chairpersons:Wolfgang Oertel, Germany and Federica Provini, Italy


Data Base Augmentation

Website

Others